Provider of contract research and technology services. The company specializes in screening, assay development, optimization, target production and access to chemical libraries which helps to identify small molecules with desired biological activity.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 31-Dec-2000 | $7.2M | 00.00 | Completed | Startup | |
1. Early Stage VC | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Helmut Kessmann Ph.D | Senior Vice President of Business Development & Marketing |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Novartis Venture Fund | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |